EBMT

What EBMT does

EBMT (European Group for Blood and Marrow Transplantation) is a non-profit medical society founded in 1974 and registered in the Netherlands, with headquarters in London and operational offices in Barcelona, Leiden and Paris. The organization operates Europe's largest longitudinal patient registry for haematopoietic cell transplantation (HCT), CAR-T cell therapy and gene therapy, tracking 820,777 patients and 937,572 transplants across member centres. EBMT serves a member community of healthcare centres, transplant clinicians, research nurses, statisticians and data managers, structured around 13 disease- and modality-specific Working Parties that design and execute clinical studies. Its flagship service is the EBMT Registry, supplemented by EuroTraCTOR for transplant activity tracking and the GoCART Coalition for immune effector cell therapy research.

The society monetizes through a recurring membership model (institutional and individual), JACIE accreditation fees from 256 certified centres, an annual scientific meeting, regional educational events, an e-learning platform, and a catalogue of reference publications (EBMT Handbook, EU CAR-T Handbook, EBMT Textbook for Nurses, JACIE Inspector Handbook). JACIE (Joint Accreditation Committee ISCT and EBMT) functions as a recognized quality standard for HCT and cellular therapy practice across Europe, giving the society quasi-regulatory standing. EBMT supplements member and certification income with grants and sponsorship from a network of 15+ pharmaceutical partners, including Bristol Myers Squibb, Novartis, Pfizer, Gilead/Kite, Sanofi, Vertex, Alexion, CSL Behring and Jazz Pharmaceuticals.

Operationally, EBMT is governed by a Managing Director (Yann Mahé), a Chief Medical Officer and Education Director (Isabel Sánchez-Ortega), and a wider executive team spanning Registry, Clinical Study, Quality of Care, Congress, and Community Relations functions, supported by 130+ staff across three offices. The leadership structure reflects the dual demands of running a regulated clinical data registry and a multi-stakeholder scientific community, with annual reports, registry release updates and a public 2024 Activity Report indicating continued operational scaling.

Name

EBMT

Legal name

European Group for Blood and Marrow Transplantation (EBMT)

Website

https://ebmt.org

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

51–100 employees

Short description

EBMT is a non-profit medical society founded in 1974 that runs Europe's largest patient registry for haematopoietic cell transplantation, CAR-T, and gene therapies. It serves 256+ JACIE-certified healthcare centres, clinicians, and researchers through membership, accreditation, clinical studies, and education.

Ownership category

akta.pro rank

Product category

Medical Society and Patient Registry Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAFAI

Bone Marrow & Stem Cell Transplant (BMT/HSCT)

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAIAAAO

Transplantation & Advanced Therapies Pharmaceuticals (incl. Cell & Gene Therapies)

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAFAHAE

Transplant Specialty Hospitals

Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care

Keywords

• Haematopoietic cell transplantation
• Cellular therapy registry
• Stem cell transplantation
• CAR-T data tracking
• Clinical research networks

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Membership Fees: EBMT operates as a membership-based society where healthcare centres and professionals join to access the registry, participate in research, and benefit from educational resources and certification programs.
2. JACIE Certification: Voluntary certification program for centres in haematopoietic cell transplantation and cellular therapy, providing accreditation services to ensure high-quality patient care and medical practice standards.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

EBMT operates a comprehensive patient Registry tracking haematopoietic cell transplantation (HCT), CAR-T treatments, gene therapies, and immunosuppressive treatments across Europe, alongside voluntary JACIE accreditation for transplant centres and educational programs including handbooks, e-learning, and the annual meeting. The organization serves as a scientific society connecting healthcare centres, clinicians, and researchers working in blood and marrow transplantation.

Product overview

EBMT operates as a unified platform-plus-services organization centered on its patient Registry, which is the backbone of its research and educational activities. The core Registry tracks patients across HCT, CAR-T, and gene therapies, supporting clinical studies through various Working Parties. Educational offerings include handbooks (EBMT Handbook, EU CAR-T Handbook, EBMT Textbook for Nurses, JACIE Guide, JACIE Inspector Handbook) and an E-learning platform. JACIE Certification provides voluntary accreditation for transplant centers. The GoCART Coalition and EuroTraCTOR support specialized research initiatives.

Differentiator

Problem solved

Functional benefit

Brands

• JACIE: Joint Accreditation Committee ISCT and EBMT - a voluntary certification program for haematopoietic progenitor cell transplantation and cellular therapy.

Products and services

• EBMT Patient Registry Central database tracking patients who have undergone haematopoietic cell transplantation (HCT) and cellular therapies across Europe. Contains data on over 820,000 patients, 937,572 transplants, 19,233 CAR-T treatments, and 89 gene therapies.
• JACIE Certification Voluntary certification program for haematopoietic cell transplantation and cellular therapy centres, with 256 certified centres. Covers standards for high-quality patient care and medical and laboratory practice.
• EBMT Handbook Comprehensive reference book for EBMT members covering stem cell transplantation practices and protocols.
• The EU CAR-T Handbook Reference handbook covering European CAR-T cell therapy practices and clinical guidance.
• The EBMT Textbook for Nurses Specialized textbook for nursing professionals in the field of blood and marrow transplantation.
• JACIE Guide Guide providing standards and requirements for JACIE accreditation in haematopoietic stem cell transplantation and cellular therapy.
• JACIE Inspector Handbook Handbook for inspectors conducting JACIE accreditation assessments of transplant centres.
• E-learning Platform Online learning platform providing educational courses and materials for EBMT members including preparatory courses for physicians and nurses.
• EBMT Studies Platform Platform for managing and conducting EBMT clinical studies across various working parties covering diseases including leukaemia, lymphoma, autoimmune diseases, and hemoglobinopathies.
• GoCART Coalition Coalition focused on advancing cellular therapy research and data collection for immune effector cell therapies.
• EuroTraCTOR European tracking system for transplant activity and outcomes data.

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

16 partnerships are on record, tiered core and minor.

• Bristol Myers SquibbcoreOthersPharmaceutical company partner listed on EBMT Partners page. BMS develops medicines for serious diseases including cancer and血液病.
• AutoluscoreOthersBiotechnology company focused on T-cell therapy, listed as EBMT partner.
• Kite Pharma (Gilead)coreOthersCAR-T cell therapy company, subsidiary of Gilead Sciences, listed as EBMT partner.
• Kyowa KirincoreOthersJapan-based pharmaceutical company listed as EBMT partner.
• NovartiscoreOthersGlobal pharmaceutical company listed as EBMT partner.
• SanoficoreOthersGlobal pharmaceutical company listed as EBMT partner.
• VertexcoreOthersBiotechnology company listed as EBMT partner.
• AlexioncoreOthersAstraZeneca rare disease unit, listed as EBMT partner.
• CordexminorOthersBiotechnology company listed as EBMT partner.
• CSL BehringcoreOthersBiotherapeutics company listed as EBMT partner.
• Jazz PharmaceuticalscoreOthersPharmaceutical company listed as EBMT partner.
• MedacminorOthersPharmaceutical company listed as EBMT partner.
• MundipharmaminorOthersPharmaceutical company listed as EBMT partner.
• OrcabiominorOthersListed as EBMT partner.
• PfizercoreOthersGlobal pharmaceutical company listed as EBMT partner.
• Tscan TherapeuticsminorOthersT-cell receptor therapy company listed as EBMT partner.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Regional players

• BSBMT (British Society of Blood and Marrow Transplantation): BSBMT is a UK national affiliate society for HCT professionals that operates alongside EBMT at the national level, sharing a mission and member base but bounded to the UK.

Direct peers

• ASTCT (American Society for Transplant and Cellular Therapy): ASTCT is the leading US professional society for blood and marrow transplantation and cellular therapy, serving as the American counterpart to EBMT in physician membership, education and accreditation activities (FACT).
• CIBMTR (Center for International Blood and Marrow Transplant Research): CIBMTR is the US-based research collaboration that maintains a patient outcomes registry for hematopoietic cell transplantation, the direct functional analogue of the EBMT Registry on the North American side.
• WMDA (World Marrow Donor Association): WMDA coordinates the international registry of volunteer unrelated marrow donors that ultimately feeds transplant activity tracked in registries like EBMT's, making it a closely coupled ecosystem peer.
• FACT (Foundation for the Accreditation of Cellular Therapy): FACT provides voluntary accreditation for cellular therapy and transplant programmes alongside EBMT/JACIE and competes for the same centre-level accreditation mandates internationally.
• ISCT (International Society for Cell & Gene Therapy): ISCT is the global society for cell and gene therapy and is EBMT's joint partner in JACIE accreditation, addressing overlapping membership, standards-setting and educational missions in cellular therapies.

Broad incumbents

• EHA (European Hematology Association): EHA is the broader European hematology society that overlaps with EBMT's physician audience but covers all hematology, not the focused transplantation/cellular-therapy niche that EBMT serves.
• ASH (American Society of Hematology): ASH is the largest US hematology professional society with similar educational-meeting and journal economics, addressing a broader hematology audience that overlaps with EBMT's clinical membership.

Others

• EBMT Cellular Therapy & Immunobiology Working Party partners (e.g., GoCART Coalition): The GoCART Coalition is an EBMT-hosted research coalition on immune effector cell therapies that operates in adjacent cellular-therapy data and registry space, relevant as a programmatic peer.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/TheEBMT
• YouTubeyoutube.com/user/TheEBMT
• Facebookfacebook.com/TheEBMT
• LinkedInlinkedin.com/company/european-society-for-blood-and-marrow-transplantation
• Instagraminstagram.com/theebmt

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EBMT